Accumulated evidence has associated the overexpression of COX-2 with the progression of DN, with COX-2 inhibition reducing hyperfiltration and proteinuria, abrogating Ang II-mediated reductions in GFR, and retarding progressive renal injury (72–75). This evidence concerns the gene AGT and liver dysplastic nodule.